RPTX

Repare Therapeutics Inc.CIK 1808158 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for RPTX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for RPTX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Alves Sandra Isabelle Barros	SVP, Finance and CAO	5	$0	$0	2026-01-28
Forte Steve	EVP, Chief Financial Officer	23	$100.0K	$26.9K	2026-01-28
Civik Thomas	Director	6	$210.6K	$0	2026-01-28
SCHAFER CAROL	Director	7	$160.0K	$0	2026-01-28
RHOADS ANN D	Director	7	$80.0K	$0	2026-01-28
BVF PARTNERS L P/IL	10% Owner	3	$0	$0	2026-01-28
Koehler Maria	EVP, Chief Medical Officer	25	$0	$14.8K	2025-03-12
Zinda Michael	EVP, Chief Scientific Officer	72	$0	$6.74M	2025-03-12
Segal Lloyd Mitchell	President and CEO	29	$100.0K	$1.99M	2025-03-12
Kulkarni Samarth	Director	4	$0	$0	2024-06-17
Stein Steven H	Director	1	$0	$0	2024-06-17
Morrison Briggs	Director	5	$96.0K	$0	2024-06-17
Bonita David P	Director	38	$15.48M	$4.19M	2024-06-17
Molineaux Susan	Director	2	$0	$0	2024-06-17
Biotechnology Value Trading Fund OS LP	Other	9	$9.07M	$0	2023-11-16
Foley Todd	Director	60	$5.00M	$22.12M	2023-06-08
Jerel Davis	Director, 10% Owner	144	$5.00M	$13.19M	2022-12-29
BIOTECHNOLOGY VALUE FUND II LP	Other	6	$15.97M	$0	2022-06-13
BVF II GP LLC	Other	9	$21.86M	$0	2022-06-06
Versant Vantage I, L.P.	10% Owner	83	$5.00M	$9.19M	2022-06-06
Versant Venture Capital V, L.P.	10% Owner	15	$0	$9.19M	2022-06-06
BVF GP HOLDINGS LLC	10% Owner	3	$3.57M	$0	2022-05-18
OrbiMed Capital GP VII LLC	Director	4	$0	$274.8K	2021-09-07
ORBIMED ADVISORS LLC	Director	14	$15.48M	$1.98M	2021-09-02
ORBIMED CAPITAL LLC	Director	12	$0	$1.24M	2021-08-30
Versant Ophthalmic Affiliates I, L.P.	10% Owner	25	$0	$0	2021-08-05
GADICKE ANSBERT	10% Owner	57	$10.00M	$45.72M	2021-07-12
Versant Venture Capital V (Canada), LP	10% Owner	5	$0	$0	2021-06-01
Versant Vantage I GP, L.P.	10% Owner	30	$0	$0	2021-05-05
Versant Affiliates Fund V, L.P.	10% Owner	10	$0	$0	2021-05-05
Versant Ventures V GP-GP (Canada), Inc.	10% Owner	10	$0	$0	2021-02-16
Versant Ventures VI GP, L.P.	10% Owner	20	$0	$0	2021-01-29
Versant Venture Capital VI, L.P.	10% Owner	4	$0	$0	2020-12-15
Versant Ventures VI GP-GP, LLC	10% Owner	24	$5.00M	$0	2020-06-23
Redmile Group, LLC	10% Owner	2	$0	$0	2020-06-23
EVNIN LUKE	10% Owner	5	$5.00M	$0	2020-06-23

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Alves Sandra Isabelle Barros	SVP, Finance and CAO	D To issuer deriv	2026-01-28	2026-01-28	24,500	—	$0	0	SEC↗
Alves Sandra Isabelle Barros	SVP, Finance and CAO	D To issuer deriv	2026-01-28	2026-01-28	26,000	—	$0	0	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	D To issuer deriv	2026-01-28	2026-01-28	200,000	—	$0	0	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	D To issuer deriv	2026-01-28	2026-01-28	85,000	—	$0	0	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	D To issuer deriv	2026-01-28	2026-01-28	500,000	—	$0	0	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	D To issuer deriv	2026-01-28	2026-01-28	325,800	—	$0	0	SEC↗
SCHAFER CAROL	Director	D To issuer deriv	2026-01-28	2026-01-28	37,941	—	$0	0	SEC↗
Alves Sandra Isabelle Barros	SVP, Finance and CAO	D To issuer	2026-01-28	2026-01-28	31,622	—	$0	0	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	D To issuer	2026-01-28	2026-01-28	56,786	—	$0	0	SEC↗
Civik Thomas	Director	D To issuer	2026-01-28	2026-01-28	7,500	—	$0	0	SEC↗
RHOADS ANN D	Director	D To issuer	2026-01-28	2026-01-28	4,000	—	$0	0	SEC↗
SCHAFER CAROL	Director	D To issuer	2026-01-28	2026-01-28	8,000	—	$0	0	SEC↗
BVF PARTNERS L P/IL	10% Owner	U Tender	2026-01-28	2026-01-30	548,938	—	$0	0	SEC↗
BVF PARTNERS L P/IL	10% Owner	U Tender	2026-01-28	2026-01-30	5,309,432	—	$0	0	SEC↗
BVF PARTNERS L P/IL	10% Owner	U Tender	2026-01-28	2026-01-30	4,308,573	—	$0	0	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	A Award deriv	2025-04-02	2025-04-04	500,000	—	$0	500,000	SEC↗
Alves Sandra Isabelle Barros	SVP, Finance and CAO	A Award deriv	2025-04-02	2025-04-29	24,500	—	$0	24,500	SEC↗
Alves Sandra Isabelle Barros	SVP, Finance and CAO	A Award	2025-04-02	2025-04-29	4,100	—	$0	29,622	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	S Sale	2025-03-12	2025-03-14	21,179	$1.14	$24.1K	124,394	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	S Sale	2025-03-12	2025-03-14	6,884	$1.14	$7.8K	54,786	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	S Sale	2025-03-12	2025-03-14	5,611	$1.14	$6.4K	80,297	SEC↗
Koehler Maria	EVP, CHIEF MEDICAL OFFICER	S Sale	2025-03-12	2025-03-14	3,596	$1.14	$4.1K	227,813	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	A Award deriv	2025-03-04	2025-03-06	85,000	—	$0	85,000	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	A Award deriv	2025-03-04	2025-03-06	200,000	—	$0	200,000	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	A Award deriv	2025-03-04	2025-03-06	85,000	—	$0	85,000	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	A Award deriv	2025-03-04	2025-03-06	75,000	—	$0	75,000	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	A Award deriv	2025-03-04	2025-03-06	237,000	—	$0	237,000	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	A Award	2025-03-04	2025-03-06	14,000	—	$0	61,670	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	A Award	2025-03-04	2025-03-06	14,000	—	$0	85,908	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	A Award	2025-03-04	2025-03-06	40,000	—	$0	145,573	SEC↗
Stein Steven H	Director	A Award deriv	2024-06-17	2024-06-20	54,000	—	$0	54,000	SEC↗
Civik Thomas	Director	A Award deriv	2024-06-17	2024-06-20	27,200	—	$0	27,200	SEC↗
Bonita David P	Director	A Award deriv	2024-06-17	2024-06-20	27,200	—	$0	27,200	SEC↗
Kulkarni Samarth	Director	A Award deriv	2024-06-17	2024-06-20	27,200	—	$0	27,200	SEC↗
Molineaux Susan	Director	A Award deriv	2024-06-17	2024-06-20	27,200	—	$0	27,200	SEC↗
Morrison Briggs	Director	A Award deriv	2024-06-17	2024-06-20	27,200	—	$0	27,200	SEC↗
RHOADS ANN D	Director	A Award deriv	2024-06-17	2024-06-20	27,200	—	$0	27,200	SEC↗
SCHAFER CAROL	Director	A Award deriv	2024-06-17	2024-06-20	27,200	—	$0	27,200	SEC↗
Koehler Maria	EVP, CHIEF MEDICAL OFFICER	S Sale	2024-04-01	2024-04-01	300	$4.66	$1.4K	231,409	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	S Sale	2024-04-01	2024-04-01	410	$4.66	$1.9K	71,908	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	S Sale	2024-04-01	2024-04-01	789	$4.61	$3.6K	44,775	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	S Sale	2024-04-01	2024-04-01	2,491	$4.63	$11.5K	107,558	SEC↗
Koehler Maria	EVP, CHIEF MEDICAL OFFICER	S Sale	2024-03-28	2024-04-01	500	$4.64	$2.3K	231,709	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	S Sale	2024-03-28	2024-04-01	450	$4.64	$2.1K	72,318	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	S Sale	2024-03-28	2024-04-01	825	$4.62	$3.8K	45,564	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	S Sale	2024-03-28	2024-04-01	2,650	$4.62	$12.2K	110,049	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	S Sale	2024-03-27	2024-03-27	2,650	$4.63	$12.3K	83,866	SEC↗
Koehler Maria	EVP, CHIEF MEDICAL OFFICER	S Sale	2024-03-27	2024-03-27	500	$4.62	$2.3K	232,209	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	S Sale	2024-03-27	2024-03-27	450	$4.62	$2.1K	72,768	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	S Sale	2024-03-27	2024-03-27	825	$4.62	$3.8K	42,212	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	S Sale	2024-03-26	2024-03-27	2,650	$4.64	$12.3K	86,516	SEC↗
Koehler Maria	EVP, CHIEF MEDICAL OFFICER	S Sale	2024-03-26	2024-03-27	500	$4.60	$2.3K	232,709	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	S Sale	2024-03-26	2024-03-27	450	$4.61	$2.1K	73,218	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	S Sale	2024-03-26	2024-03-27	825	$4.60	$3.8K	43,037	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	S Sale	2024-03-25	2024-03-27	2,650	$4.79	$12.7K	89,166	SEC↗
Koehler Maria	EVP, CHIEF MEDICAL OFFICER	S Sale	2024-03-25	2024-03-27	500	$4.78	$2.4K	233,209	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	S Sale	2024-03-25	2024-03-27	450	$4.78	$2.2K	73,668	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	S Sale	2024-03-25	2024-03-27	825	$4.79	$4.0K	43,862	SEC↗
Koehler Maria	EVP, CHIEF MEDICAL OFFICER	A Award deriv	2024-03-01	2024-03-04	85,000	—	$0	85,000	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	A Award deriv	2024-03-01	2024-03-04	237,000	—	$0	237,000	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	A Award deriv	2024-03-01	2024-03-04	85,000	—	$0	85,000	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	A Award deriv	2024-03-01	2024-03-05	85,000	—	$0	85,000	SEC↗
Koehler Maria	EVP, CHIEF MEDICAL OFFICER	A Award	2024-03-01	2024-03-04	14,000	—	$0	233,709	SEC↗
Segal Lloyd Mitchell	PRESIDENT AND CEO	A Award	2024-03-01	2024-03-04	40,000	—	$0	124,677	SEC↗
Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICE	A Award	2024-03-01	2024-03-04	14,000	—	$0	74,118	SEC↗
Forte Steve	EVP, CHIEF FINANCIAL OFFICER	A Award	2024-03-01	2024-03-05	14,000	—	$0	44,687	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise deriv	2023-12-11	2023-12-12	20,190	—	$0	24,229	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise deriv	2023-12-11	2023-12-12	23,556	—	$0	87,691	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise	2023-12-11	2023-12-12	20,190	$2.06	$41.6K	196,153	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise	2023-12-11	2023-12-12	23,556	$2.43	$57.2K	219,709	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-16	2023-11-17	153,693	$5.38	$826.9K	5,309,432	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-16	2023-11-17	125,909	$5.38	$677.4K	4,308,573	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-16	2023-11-17	16,143	$5.38	$86.8K	548,938	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-15	2023-11-17	47,712	$5.00	$238.6K	532,795	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-15	2023-11-17	493,337	$5.00	$2.47M	5,155,739	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-15	2023-11-17	390,507	$5.00	$1.95M	4,182,664	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-02	2023-11-03	218,979	$3.60	$788.3K	4,662,402	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-02	2023-11-03	72,479	$3.60	$260.9K	485,083	SEC↗
Biotechnology Value Trading Fu	Other	P Buy	2023-11-02	2023-11-03	492,251	$3.60	$1.77M	3,792,157	SEC↗
Bonita David P	Director	A Award deriv	2023-06-08	2023-06-12	27,200	—	$0	27,200	SEC↗
Civik Thomas	Director	A Award deriv	2023-06-08	2023-06-12	27,200	—	$0	27,200	SEC↗
Foley Todd	Director	A Award deriv	2023-06-08	2023-06-12	27,200	—	$0	27,200	SEC↗
Kulkarni Samarth	Director	A Award deriv	2023-06-08	2023-06-12	27,200	—	$0	27,200	SEC↗
Molineaux Susan	Director	A Award deriv	2023-06-08	2023-06-12	76,200	—	$0	76,200	SEC↗
Morrison Briggs	Director	A Award deriv	2023-06-08	2023-06-12	27,200	—	$0	27,200	SEC↗
RHOADS ANN D	Director	A Award deriv	2023-06-08	2023-06-12	27,200	—	$0	27,200	SEC↗
SCHAFER CAROL	Director	A Award deriv	2023-06-08	2023-06-12	27,200	—	$0	27,200	SEC↗
Zinda Michael	EVP, Chief Scientific Office	S Sale	2023-06-08	2023-06-09	2,869	$12.02	$34.5K	60,118	SEC↗
Zinda Michael	EVP, Chief Scientific Office	S Sale	2023-06-07	2023-06-09	6,404	$12.03	$77.0K	62,987	SEC↗
Zinda Michael	EVP, Chief Scientific Office	S Sale	2023-06-06	2023-06-07	1,200	$12.04	$14.4K	69,391	SEC↗
Forte Steve	EVP, Chief Financial Officer	A Award deriv	2023-01-30	2023-02-01	111,050	—	$0	111,050	SEC↗
Segal Lloyd Mitchell	President and CEO	A Award deriv	2023-01-30	2023-02-01	344,200	—	$0	344,200	SEC↗
Koehler Maria	EVP, Chief Medical Officer	A Award deriv	2023-01-30	2023-02-01	119,250	—	$0	119,250	SEC↗
Zinda Michael	EVP, Chief Scientific Office	A Award deriv	2023-01-30	2023-02-01	97,100	—	$0	97,100	SEC↗
Forte Steve	EVP, Chief Financial Officer	A Award	2023-01-30	2023-02-01	24,530	—	$0	30,687	SEC↗
Segal Lloyd Mitchell	President and CEO	A Award	2023-01-30	2023-02-01	78,550	—	$0	84,677	SEC↗
Koehler Maria	EVP, Chief Medical Officer	A Award	2023-01-30	2023-02-01	26,450	—	$0	175,963	SEC↗
Zinda Michael	EVP, Chief Scientific Office	A Award	2023-01-30	2023-02-01	24,550	—	$0	70,591	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	3,014	—	$0	25,131	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	4,721	—	$0	0	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	4,721	—	$0	4,721	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	21,854	—	$0	42,877	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	1,240	—	$0	22,117	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	65,957	—	$0	0	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	2,065	—	$0	65,957	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	9,561	—	$0	18,761	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	1,866	—	$0	63,892	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	8,638	—	$0	16,949	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	62,026	—	$0	62,026	SEC↗
Jerel Davis	Director	J Other	2022-12-29	2023-01-03	287,157	—	$0	563,403	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise deriv	2022-12-20	2022-12-20	51	—	$0	111,247	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise deriv	2022-12-20	2022-12-20	48,456	—	$0	44,419	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise	2022-12-20	2022-12-20	51	$2.43	$124	149,513	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise	2022-12-20	2022-12-20	48,456	$2.06	$99.8K	149,462	SEC↗
Jerel Davis	Director	S Sale	2022-12-09	2022-12-13	250,000	$16.00	$4.00M	2,094,451	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2022-06-13	2022-06-15	68,327	$12.73	$869.8K	3,299,906	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2022-06-13	2022-06-15	74,666	$12.73	$950.5K	4,443,423	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2022-06-13	2022-06-15	6,168	$12.73	$78.5K	412,604	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-06	2022-06-06	3,040	$13.21	$40.2K	3,231,579	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-06	2022-06-06	20	$13.21	$264	406,436	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-06	2022-06-06	3,809	$13.21	$50.3K	4,368,757	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	46,753	—	$0	64,731	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	2,653	—	$0	14,429	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	141,103	—	$0	0	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	4,419	—	$0	141,103	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	20,454	—	$0	28,322	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	3,992	—	$0	136,684	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	18,478	—	$0	25,587	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	132,692	—	$0	132,692	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	614,315	—	$0	850,560	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	10,099	—	$0	10,099	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	10,099	—	$0	0	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2022-06-06	2022-06-07	6,448	—	$0	20,877	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	614,315	—	$0	850,560	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	10,099	—	$0	0	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	10,099	—	$0	10,099	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	46,753	—	$0	64,731	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	141,103	—	$0	0	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	4,419	—	$0	141,103	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	20,454	—	$0	28,322	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	3,992	—	$0	136,684	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	18,478	—	$0	25,587	SEC↗
Versant Venture Capital V, L.P	10% Owner	J Other	2022-06-06	2022-06-07	132,692	—	$0	132,692	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	614,315	—	$0	850,560	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	18,478	—	$0	25,587	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	3,992	—	$0	136,684	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	20,454	—	$0	28,322	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	4,419	—	$0	141,103	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	141,103	—	$0	0	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	10,099	—	$0	0	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	10,099	—	$0	10,099	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	46,753	—	$0	64,731	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2022-06-06	2022-06-07	132,692	—	$0	132,692	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-03	2022-06-06	258,797	$12.29	$3.18M	3,228,539	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-03	2022-06-06	353,344	$12.29	$4.34M	4,364,948	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-03	2022-06-06	31,903	$12.29	$392.1K	406,416	SEC↗
Jerel Davis	Director, 10% Owner	S Sale	2022-06-03	2022-06-07	33,395	$12.25	$409.1K	111,484	SEC↗
Jerel Davis	Director, 10% Owner	S Sale	2022-06-03	2022-06-07	14,611	$12.25	$179.0K	48,776	SEC↗
Jerel Davis	Director, 10% Owner	S Sale	2022-06-03	2022-06-07	13,199	$12.25	$161.7K	44,065	SEC↗
Jerel Davis	Director, 10% Owner	S Sale	2022-06-03	2022-06-07	438,795	$12.25	$5.38M	1,464,875	SEC↗
Jerel Davis	Director, 10% Owner	S Sale	2022-06-03	2022-06-07	250,000	$12.25	$3.06M	2,344,451	SEC↗
Versant Venture Capital V, L.P	10% Owner	S Sale	2022-06-03	2022-06-07	250,000	$12.25	$3.06M	2,344,451	SEC↗
Versant Venture Capital V, L.P	10% Owner	S Sale	2022-06-03	2022-06-07	438,795	$12.25	$5.38M	1,464,875	SEC↗
Versant Venture Capital V, L.P	10% Owner	S Sale	2022-06-03	2022-06-07	13,199	$12.25	$161.7K	44,065	SEC↗
Versant Venture Capital V, L.P	10% Owner	S Sale	2022-06-03	2022-06-07	33,395	$12.25	$409.1K	111,484	SEC↗
Versant Venture Capital V, L.P	10% Owner	S Sale	2022-06-03	2022-06-07	14,611	$12.25	$179.0K	48,776	SEC↗
Versant Vantage I, L.P.	10% Owner	S Sale	2022-06-03	2022-06-07	33,395	$12.25	$409.1K	111,484	SEC↗
Versant Vantage I, L.P.	10% Owner	S Sale	2022-06-03	2022-06-07	14,611	$12.25	$179.0K	48,776	SEC↗
Versant Vantage I, L.P.	10% Owner	S Sale	2022-06-03	2022-06-07	13,199	$12.25	$161.7K	44,065	SEC↗
Versant Vantage I, L.P.	10% Owner	S Sale	2022-06-03	2022-06-07	438,795	$12.25	$5.38M	1,464,875	SEC↗
Versant Vantage I, L.P.	10% Owner	S Sale	2022-06-03	2022-06-07	250,000	$12.25	$3.06M	2,344,451	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-02	2022-06-06	464,235	$11.68	$5.42M	2,969,742	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-02	2022-06-06	660,654	$11.68	$7.72M	4,011,604	SEC↗
BVF II GP LLC	Other	P Buy	2022-06-02	2022-06-06	61,156	$11.68	$714.3K	374,513	SEC↗
BVF GP HOLDINGS LLC	10% Owner	P Buy	2022-05-18	2022-05-20	189,882	$8.50	$1.61M	2,505,507	SEC↗
BVF GP HOLDINGS LLC	10% Owner	P Buy	2022-05-18	2022-05-20	5,730	$8.50	$48.7K	313,357	SEC↗
BVF GP HOLDINGS LLC	10% Owner	P Buy	2022-05-18	2022-05-20	224,388	$8.50	$1.91M	3,350,950	SEC↗
Bonita David P	Director	A Award deriv	2022-05-13	2022-05-16	49,000	—	$0	49,000	SEC↗
Kulkarni Samarth	Director	A Award deriv	2022-05-13	2022-05-16	49,000	—	$0	49,000	SEC↗
Morrison Briggs	Director	A Award deriv	2022-05-13	2022-05-16	49,000	—	$0	49,000	SEC↗
Jerel Davis	Director	A Award deriv	2022-05-13	2022-05-16	49,000	—	$0	49,000	SEC↗
Foley Todd	Director	A Award deriv	2022-05-13	2022-05-16	49,000	—	$0	49,000	SEC↗
RHOADS ANN D	Director	A Award deriv	2022-05-13	2022-05-16	49,000	—	$0	49,000	SEC↗
Civik Thomas	Director	A Award deriv	2022-05-13	2022-05-16	49,000	—	$0	49,000	SEC↗
SCHAFER CAROL	Director	A Award deriv	2022-05-13	2022-05-16	49,000	—	$0	49,000	SEC↗
Zinda Michael	EVP, Chief Science Officer	S Sale	2022-03-15	2022-03-16	533	$11.30	$6.0K	46,041	SEC↗
Segal Lloyd Mitchell	President and CEO	M Exercise deriv	2022-01-21	2022-01-24	300,000	—	$0	300,000	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2022-01-19	2022-01-21	7,899	$14.10	$111.4K	307,627	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2022-01-19	2022-01-21	412,264	$14.10	$5.81M	2,315,625	SEC↗
BIOTECHNOLOGY VALUE FUND II LP	Other	P Buy	2022-01-19	2022-01-21	577,798	$14.10	$8.15M	3,126,562	SEC↗
Segal Lloyd Mitchell	President and CEO	M Exercise deriv	2022-01-18	2022-01-20	300,000	—	$0	300,000	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise deriv	2022-01-18	2022-01-20	115,000	—	$0	115,000	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise deriv	2022-01-18	2022-01-20	115,000	—	$0	115,000	SEC↗
Forte Steve	EVP, Chief Financial Officer	M Exercise deriv	2022-01-18	2022-01-20	100,000	—	$0	100,000	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise deriv	2021-12-10	2021-12-10	48,460	—	$0	92,875	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise deriv	2021-12-10	2021-12-10	51	—	$0	111,298	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise	2021-12-10	2021-12-10	48,460	$2.06	$99.8K	100,955	SEC↗
Koehler Maria	EVP, Chief Medical Officer	M Exercise	2021-12-10	2021-12-10	51	$2.43	$124	101,006	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise deriv	2021-11-23	2021-12-06	4,122	—	$0	0	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise deriv	2021-11-23	2021-12-06	11,856	—	$0	0	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise deriv	2021-11-23	2021-12-06	19,590	—	$0	35,260	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise deriv	2021-11-23	2021-12-06	10,473	—	$0	137,993	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise	2021-11-23	2021-12-06	19,590	$2.06	$40.4K	36,101	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise	2021-11-23	2021-12-06	11,856	$1.64	$19.4K	16,511	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise	2021-11-23	2021-12-06	10,473	$2.43	$25.4K	46,574	SEC↗
Zinda Michael	EVP, Chief Science Officer	M Exercise	2021-11-23	2021-12-06	4,122	$1.64	$6.8K	4,655	SEC↗
Civik Thomas	Director	P Buy	2021-11-16	2021-11-18	7,500	$28.08	$210.6K	7,500	SEC↗
Zinda Michael	EVP, Chief Science Officer	S Sale	2021-11-15	2021-11-17	3,900	$27.87	$108.7K	533	SEC↗
Zinda Michael	EVP, Chief Science Officer	S Sale	2021-11-15	2021-11-17	16,100	$27.20	$437.9K	4,433	SEC↗
Civik Thomas	Director	A Award deriv	2021-09-07	2021-09-09	42,000	—	$0	42,000	SEC↗
OrbiMed Capital GP VII LLC	Director	S Sale	2021-09-07	2021-09-08	26	$33.93	$882	96,190	SEC↗
OrbiMed Capital GP VII LLC	Director	S Sale	2021-09-07	2021-09-08	861	$33.93	$29.2K	3,177,041	SEC↗
Bonita David P	Director	S Sale	2021-09-07	2021-09-08	861	$33.93	$29.2K	3,177,041	SEC↗
Bonita David P	Director	S Sale	2021-09-07	2021-09-08	26	$33.93	$882	96,190	SEC↗
OrbiMed Capital GP VII LLC	Director	S Sale	2021-09-03	2021-09-08	6,985	$34.00	$237.5K	3,177,902	SEC↗
OrbiMed Capital GP VII LLC	Director	S Sale	2021-09-03	2021-09-08	212	$34.00	$7.2K	96,216	SEC↗
Bonita David P	Director	S Sale	2021-09-03	2021-09-08	6,985	$34.00	$237.5K	3,177,902	SEC↗
Bonita David P	Director	S Sale	2021-09-03	2021-09-08	212	$34.00	$7.2K	96,216	SEC↗
Bonita David P	Director	S Sale	2021-09-02	2021-09-02	15,941	$34.24	$545.8K	3,184,887	SEC↗
Bonita David P	Director	S Sale	2021-09-02	2021-09-02	483	$34.24	$16.5K	96,428	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-09-02	2021-09-02	483	$34.24	$16.5K	96,428	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-09-02	2021-09-02	15,941	$34.24	$545.8K	3,184,887	SEC↗
Bonita David P	Director	S Sale	2021-09-01	2021-09-02	382	$33.98	$13.0K	96,911	SEC↗
Bonita David P	Director	S Sale	2021-09-01	2021-09-02	12,586	$33.98	$427.7K	3,200,828	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-09-01	2021-09-02	382	$33.98	$13.0K	96,911	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-09-01	2021-09-02	12,586	$33.98	$427.7K	3,200,828	SEC↗
Bonita David P	Director	S Sale	2021-08-31	2021-09-02	249	$33.94	$8.5K	97,293	SEC↗
Bonita David P	Director	S Sale	2021-08-31	2021-09-02	8,223	$33.94	$279.1K	3,213,414	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-08-31	2021-09-02	249	$33.94	$8.5K	97,293	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-08-31	2021-09-02	8,223	$33.94	$279.1K	3,213,414	SEC↗
Bonita David P	Director	S Sale	2021-08-30	2021-08-30	197	$33.92	$6.7K	97,542	SEC↗
Bonita David P	Director	S Sale	2021-08-30	2021-08-30	6,500	$33.92	$220.5K	3,221,637	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-30	2021-08-30	197	$33.92	$6.7K	97,542	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-30	2021-08-30	6,500	$33.92	$220.5K	3,221,637	SEC↗
Bonita David P	Director	S Sale	2021-08-27	2021-08-30	6,884	$33.94	$233.6K	3,228,137	SEC↗
Bonita David P	Director	S Sale	2021-08-27	2021-08-30	209	$33.94	$7.1K	97,739	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-27	2021-08-30	209	$33.94	$7.1K	97,739	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-27	2021-08-30	6,884	$33.94	$233.6K	3,228,137	SEC↗
Bonita David P	Director	S Sale	2021-08-26	2021-08-30	4,157	$34.52	$143.5K	3,235,021	SEC↗
Bonita David P	Director	S Sale	2021-08-26	2021-08-30	126	$34.52	$4.3K	97,948	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-26	2021-08-30	126	$34.52	$4.3K	97,948	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-26	2021-08-30	4,157	$34.52	$143.5K	3,235,021	SEC↗
Bonita David P	Director	S Sale	2021-08-25	2021-08-25	208	$34.34	$7.1K	98,074	SEC↗
Bonita David P	Director	S Sale	2021-08-25	2021-08-25	6,874	$34.34	$236.1K	3,239,178	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-25	2021-08-25	208	$34.34	$7.1K	98,074	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-25	2021-08-25	6,874	$34.34	$236.1K	3,239,178	SEC↗
Bonita David P	Director	S Sale	2021-08-24	2021-08-25	119	$34.07	$4.1K	98,282	SEC↗
Bonita David P	Director	S Sale	2021-08-24	2021-08-25	3,920	$34.07	$133.6K	3,246,052	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-24	2021-08-25	119	$34.07	$4.1K	98,282	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-24	2021-08-25	3,920	$34.07	$133.6K	3,246,052	SEC↗
Bonita David P	Director	S Sale	2021-08-23	2021-08-25	209	$34.06	$7.1K	98,401	SEC↗
Bonita David P	Director	S Sale	2021-08-23	2021-08-25	6,885	$34.06	$234.5K	3,249,972	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-23	2021-08-25	209	$34.06	$7.1K	98,401	SEC↗
ORBIMED CAPITAL LLC	Director	S Sale	2021-08-23	2021-08-25	6,885	$34.06	$234.5K	3,249,972	SEC↗
Bonita David P	Director	S Sale	2021-08-18	2021-08-19	2,852	$33.99	$96.9K	3,256,857	SEC↗
Bonita David P	Director	S Sale	2021-08-18	2021-08-19	78	$33.99	$2.7K	98,610	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-08-18	2021-08-19	2,852	$33.99	$96.9K	3,256,857	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-08-18	2021-08-19	78	$33.99	$2.7K	98,610	SEC↗
Bonita David P	Director	S Sale	2021-08-18	2021-08-25	78	$33.99	$2.7K	98,610	SEC↗
Bonita David P	Director	S Sale	2021-08-18	2021-08-25	2,852	$33.99	$96.9K	3,256,857	SEC↗
Bonita David P	Director	S Sale	2021-08-17	2021-08-19	512	$34.12	$17.5K	98,688	SEC↗
Bonita David P	Director	S Sale	2021-08-17	2021-08-19	16,886	$34.12	$576.2K	3,259,439	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-08-17	2021-08-19	512	$34.12	$17.5K	98,688	SEC↗
ORBIMED ADVISORS LLC	Director	S Sale	2021-08-17	2021-08-19	16,886	$34.12	$576.2K	3,259,439	SEC↗
Bonita David P	Director	S Sale	2021-08-17	2021-08-25	512	$34.12	$17.5K	98,688	SEC↗
Bonita David P	Director	S Sale	2021-08-17	2021-08-25	16,886	$34.12	$576.2K	3,259,439	SEC↗
Zinda Michael	EVP, Chief Science Officer	S Sale	2021-08-16	2021-08-20	14,300	$33.97	$485.8K	21,233	SEC↗
Zinda Michael	EVP, Chief Science Officer	S Sale	2021-08-16	2021-08-20	700	$34.45	$24.1K	20,533	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2021-08-05	2021-08-09	2,279	—	$0	2,279	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2021-08-05	2021-08-09	152,071	—	$0	231,211	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2021-08-05	2021-08-09	2,260	—	$0	0	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2021-08-05	2021-08-09	2,260	—	$0	2,260	SEC↗
Versant Vantage I, L.P.	10% Owner	J Other	2021-08-05	2021-08-09	2,279	—	$0	0	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2021-08-05	2021-08-09	152,071	—	$0	231,211	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2021-08-05	2021-08-09	2,260	—	$0	0	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2021-08-05	2021-08-09	2,260	—	$0	2,260	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2021-08-05	2021-08-09	19	—	$0	11,776	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2021-08-05	2021-08-09	2,279	—	$0	0	SEC↗
Jerel Davis	Director, 10% Owner	J Other	2021-08-05	2021-08-09	2,279	—	$0	2,279	SEC↗
Versant Ophthalmic Affiliates	10% Owner	J Other	2021-08-05	2021-08-09	152,071	—	$0	231,211	SEC↗
Versant Ophthalmic Affiliates	10% Owner	J Other	2021-08-05	2021-08-09	2,260	—	$0	0	SEC↗
Versant Ophthalmic Affiliates	10% Owner	J Other	2021-08-05	2021-08-09	2,260	—	$0	2,260	SEC↗
Versant Ophthalmic Affiliates	10% Owner	J Other	2021-08-05	2021-08-09	2,279	—	$0	0	SEC↗
Versant Ophthalmic Affiliates	10% Owner	J Other	2021-08-05	2021-08-09	2,279	—	$0	2,279	SEC↗
GADICKE ANSBERT	10% Owner	S Sale	2021-07-12	2021-07-13	711	$34.10	$24.2K	3,882,485	SEC↗
GADICKE ANSBERT	10% Owner	S Sale	2021-07-12	2021-07-13	57,301	$33.58	$1.92M	3,883,196	SEC↗
Foley Todd	Director	S Sale	2021-07-12	2021-07-13	313	$34.10	$10.7K	2,242,636	SEC↗
Foley Todd	Director	S Sale	2021-07-12	2021-07-13	25,246	$33.58	$847.8K	2,242,949	SEC↗
GADICKE ANSBERT	10% Owner	S Sale	2021-07-09	2021-07-13	4,067	$33.06	$134.5K	3,940,497	SEC↗
Foley Todd	Director	S Sale	2021-07-09	2021-07-13	1,792	$33.06	$59.2K	2,268,195	SEC↗
GADICKE ANSBERT	10% Owner	S Sale	2021-06-29	2021-06-30	2,700	$33.29	$89.9K	3,944,564	SEC↗
Foley Todd	Director	S Sale	2021-06-29	2021-06-30	1,190	$33.29	$39.6K	2,269,987	SEC↗
GADICKE ANSBERT	10% Owner	S Sale	2021-06-28	2021-06-30	2,700	$34.82	$94.0K	3,947,264	SEC↗
GADICKE ANSBERT	10% Owner	S Sale	2021-06-28	2021-06-30	13,800	$34.06	$470.0K	3,949,964	SEC↗
Foley Todd	Director	S Sale	2021-06-28	2021-06-30	1,190	$34.82	$41.4K	2,271,177	SEC↗
Foley Todd	Director	S Sale	2021-06-28	2021-06-30	6,080	$34.06	$207.1K	2,272,367	SEC↗
Segal Lloyd Mitchell	President and CEO	S Sale	2021-06-28	2021-06-30	1,542	$35.61	$54.9K	94,466	SEC↗
GADICKE ANSBERT	10% Owner	S Sale	2021-06-25	2021-06-28	22,567	$33.51	$756.2K	3,963,764	SEC↗
Foley Todd	Director	S Sale	2021-06-25	2021-06-28	9,943	$33.51	$333.2K	2,278,447	SEC↗
GADICKE ANSBERT	10% Owner	S Sale	2021-06-24	2021-06-28	6,121	$33.53	$205.2K	3,986,331	SEC↗